Verastem, Inc.
VSTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001526119
In the last 90 days, Verastem, Inc. insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $363.5M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Verastem, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 123 | 1 | 109 | −13 |
| Shares | 109.7M | 1.07K | 127.4M | +17.7M (+16.2%) |
| Value | $127.2M | $2.00K | $108.2M | −$19.0M (−14.9%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Verastem, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| OrbiMed Advisors LLC | 17,200,000 | $14.6M | 0.29% |
| Jacobs Levy Equity Management, Inc | 378,724 | $322.0K | 0.00% |
| Bridgeway Capital Management, LLC | 355,000 | $302.0K | 0.01% |
| Connor, Clark & Lunn Investment Management Ltd. | 121,359 | $103.0K | 0.00% |
| BIT Capital GmbH | 85,000 | $72.3K | 0.01% |
| Gsa Capital Partners LLP | 64,624 | $55.0K | 0.01% |
| HRT Financial LP | 29,221 | $24.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 1,759 | $1.00K | 0.00% |
Sold out (21)
Institutions that held Verastem, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Opaleye Management Inc. | 1,590,000 | $1.84M |
| Ikarian Capital, LLC | 228,023 | $265.0K |
| Acuta Capital Partners, LLC | 200,000 | $232.0K |
| Walleye Capital LLC | 182,391 | $212.0K |
| Laurion Capital Management LP | 63,940 | $74.0K |
| Walleye Trading LLC | 60,814 | $71.0K |
| Boothbay Fund Management, LLC | 51,331 | $60.0K |
| Virtu Financial LLC | 41,048 | $48.0K |
| Y-Intercept (Hong Kong) Ltd | 25,633 | $30.0K |
| Valeo Financial Advisors, LLC | 23,500 | $27.0K |
| Kalos Management, Inc. | 20,750 | $23.0K |
| Man Group plc | – | $19.0K |
| Two Sigma Securities, LLC | 15,937 | $18.0K |
| Balyasny Asset Management LLC | 10,965 | $13.0K |
| Marshall Wace, LLP | 10,957 | $13.0K |
| Panagora Asset Management Inc | 10,102 | $12.0K |
| Capital Performance Advisors LLP | 10,000 | $12.0K |
| ACG Wealth | 2,500 | $3.00K |
| Captrust Financial Advisors | 2,110 | $2.00K |
| Evermay Wealth Management LLC | 75 | $0 |
| Ellevest, Inc. | 352 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Verastem, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Brewin Dolphin Wealth Management Ltd | 1,074 | $2.00K |